JRSIS Health Care Corporation (JRSS)
USD 0.15
(0.0%)
USD 0.15
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 28.84 Thousand USD | 43.67% |
| 2022 | -554.8 Thousand USD | -103.39% |
| 2021 | 4.1 Million USD | -1.15% |
| 2020 | 9.22 Million USD | 71.04% |
| 2019 | 8.43 Million USD | -37.01% |
| 2018 | 8.89 Million USD | -7.83% |
| 2017 | 9.25 Million USD | 23.29% |
| 2016 | 7.48 Million USD | 57.52% |
| 2015 | 4.74 Million USD | 123.23% |
| 2014 | 2.1 Million USD | 46.51% |
| 2013 | 1.44 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -105.87 Thousand USD | 39.21% |
| 2024 Q1 | -147.65 Thousand USD | -158.07% |
| 2023 Q2 | -97.23 Thousand USD | 14.8% |
| 2023 Q4 | 47.42 Thousand USD | 141.96% |
| 2023 FY | - USD | 43.67% |
| 2023 Q3 | -113.02 Thousand USD | -16.23% |
| 2023 Q1 | -114.13 Thousand USD | -297.43% |
| 2022 Q3 | -130.29 Thousand USD | -3.58% |
| 2022 Q2 | -125.78 Thousand USD | -102.59% |
| 2022 Q1 | 4.85 Million USD | 79.84% |
| 2022 FY | - USD | -103.39% |
| 2022 Q4 | -28.71 Thousand USD | 77.96% |
| 2021 Q4 | 2.7 Million USD | 41.29% |
| 2021 Q2 | 2.63 Million USD | 44.34% |
| 2021 FY | - USD | -1.15% |
| 2021 Q3 | 1.91 Million USD | -27.36% |
| 2021 Q1 | 1.82 Million USD | -48.17% |
| 2020 Q1 | 1.37 Million USD | 267.76% |
| 2020 Q2 | 1.7 Million USD | 23.7% |
| 2020 Q3 | 2.57 Million USD | 51.13% |
| 2020 Q4 | 3.51 Million USD | 36.64% |
| 2020 FY | - USD | 71.04% |
| 2019 FY | - USD | -37.01% |
| 2019 Q1 | 1.98 Million USD | 134.64% |
| 2019 Q4 | -820.63 Thousand USD | -141.2% |
| 2019 Q2 | 2.21 Million USD | 11.6% |
| 2019 Q3 | 1.99 Million USD | -10.0% |
| 2018 Q4 | 845.06 Thousand USD | -62.0% |
| 2018 FY | - USD | -7.83% |
| 2018 Q3 | 2.22 Million USD | -18.41% |
| 2018 Q2 | 2.72 Million USD | 0.32% |
| 2018 Q1 | 2.71 Million USD | -6.75% |
| 2017 Q1 | 2.18 Million USD | 9.35% |
| 2017 FY | - USD | 23.29% |
| 2017 Q4 | 2.91 Million USD | 33.5% |
| 2017 Q3 | 2.18 Million USD | 11.57% |
| 2017 Q2 | 1.95 Million USD | -10.34% |
| 2016 FY | - USD | 57.52% |
| 2016 Q2 | 1.75 Million USD | -9.67% |
| 2016 Q3 | 1.79 Million USD | 1.96% |
| 2016 Q4 | 1.99 Million USD | 11.34% |
| 2016 Q1 | 1.94 Million USD | 19.94% |
| 2015 Q1 | 955.04 Thousand USD | 73.84% |
| 2015 Q4 | 1.62 Million USD | 41.82% |
| 2015 Q3 | 1.14 Million USD | 10.6% |
| 2015 Q2 | 1.03 Million USD | 8.28% |
| 2015 FY | - USD | 123.23% |
| 2014 Q3 | 442.55 Thousand USD | -24.46% |
| 2014 FY | - USD | 46.51% |
| 2014 Q4 | 549.38 Thousand USD | 24.14% |
| 2014 Q2 | 585.81 Thousand USD | 6.07% |
| 2014 Q1 | 552.28 Thousand USD | 30.95% |
| 2013 Q1 | 336.55 Thousand USD | 0.0% |
| 2013 Q2 | 388.3 Thousand USD | 15.38% |
| 2013 Q3 | 306.88 Thousand USD | -20.97% |
| 2013 FY | - USD | 0.0% |
| 2013 Q4 | 421.76 Thousand USD | 37.44% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| The Amacore Group, Inc. | -10.98 Million USD | 100.263% |
| Arem Pacific Corporation | 36.71 Thousand USD | 21.433% |
| Assisted 4 Living, Inc. | -112.91 Thousand USD | 125.548% |
| BioCorRx Inc. | -2.68 Million USD | 101.075% |
| Bionik Laboratories Corp. | -4.77 Million USD | 100.604% |
| Banyan Corp. | 583.94 Thousand USD | 95.06% |
| Clearday, Inc. | -7.53 Million USD | 100.383% |
| Dental Patient Care America, Inc. | 12.87 Thousand USD | -124.081% |
| Quantum Medical Transport, Inc. | - USD | -Infinity% |
| Empower Clinics Inc. | -1.08 Million USD | 102.651% |
| First Choice Healthcare Solutions, Inc. | -2.2 Million USD | 101.305% |
| Selectis Health, Inc. | -7.29 Million USD | 100.395% |
| Ethema Health Corporation | 2.07 Million USD | 98.608% |
| HealthLynked Corp. | -2.75 Million USD | 101.049% |
| HQDA Elderly Life Network Corp. | - USD | -Infinity% |
| Healthcare Solutions Management Group, Inc. | -2.65 Million USD | 101.087% |
| Comjoyful International Company | 167.89 Thousand USD | 82.819% |
| Medical Facilities Corporation | 77.94 Million USD | 99.963% |
| MedSmart Group Inc. | 47.8 Thousand USD | 39.664% |
| North America Frac Sand, Inc. | -623.33 Thousand USD | 104.628% |
| Nova Leap Health Corp. | 994.46 Thousand USD | 97.099% |
| Nexteligent Holdings, Inc. | -201.73 Thousand USD | 114.299% |
| PAO Group, Inc. | 292.96 Thousand USD | 90.154% |
| Primemd Inc. | 3.42 Million USD | 99.158% |
| Raffles Medical Group Ltd | 100.7 Million USD | 99.971% |
| Ryman Healthcare Limited | -54.51 Million USD | 100.053% |
| Stem Cell Authority, Ltd. | -4233.00 USD | 781.455% |
| SETO Holdings, Inc. | - USD | -Infinity% |
| Optima Medical Innovations Corp. | -2.89 Million USD | 100.997% |
| Mycotopia Therapies, Inc. | -555.5 Thousand USD | 105.193% |
| U.S. NeuroSurgical Holdings, Inc. | -49 Thousand USD | 158.869% |
| Veltex Corporation | -938.45 Thousand USD | 103.074% |
| World Financial Holding Group | -28.43 Thousand USD | 201.463% |
| Xcelerate Inc. | -2.53 Million USD | 101.136% |